GT Biopharma, Inc.
GTBP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13,162 | -$7,597 | -$20,884 | -$58,013 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $230 | $2,200 | $7,646 | $33,929 |
| Change in WC | $828 | $1,825 | -$1,989 | $7,940 |
| Other Non-Cash | -$800 | -$5,280 | $10 | $538 |
| Operating Cash Flow | -$12,904 | -$8,852 | -$15,217 | -$15,606 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $12,893 | $0 | $12,145 | -$23,040 |
| Inv. Sales/Matur. | $0 | $0 | $12,145 | $0 |
| Other Inv. Act. | $0 | -$2,009 | -$12,145 | $0 |
| Investing Cash Flow | $12,893 | -$2,009 | $12,145 | -$23,040 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $1,205 |
| Stock Issued | $2,976 | $6,268 | $0 | $24,679 |
| Stock Repurch. | $0 | $0 | -$224 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $16,433 |
| Financing Cash Flow | $2,976 | $6,268 | -$224 | $42,317 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $2,965 | -$4,593 | -$3,296 | $3,671 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,079 | $5,672 | $8,968 | $5,297 |
| End Cash | $4,044 | $1,079 | $5,672 | $8,968 |
| Free Cash Flow | -$12,904 | -$8,852 | -$15,217 | -$15,606 |